Thermo Fisher Scientific (TMO) PT Raised to $650 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts TMO Hot Sheet
Price: $697.00 -1.72%
Rating Summary:
35 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Rating Summary:
35 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Join SI Premium – FREE
Barclays analyst Luke Sergott raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $650.00 (from $625.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Thermo Fisher Scientific (TMO) PT Raised to $780 at Argus
- Regeneron Pharma (REGN) PT Raised to $875 at Baird
- Intel (INTC) PT Lowered to $90 at Piper Sandler
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
